Prevalence and risk factors of hepatitis A infection in an HIV-infected French population

被引:5
作者
Brunet, A
Grabar, S
Blanche, P
Héripret-Fredouille, L
Spiridon, G
Calboreanu, A
Rollot, F
Launay, O
Sicard, D
Salmon-Céron, D
Abad, S
机构
[1] Univ Paris 05, Hop Cochin, Serv Informat Med, F-75679 Paris, France
[2] Univ Paris 05, Hop Cochin, Serv Med Interne, F-75679 Paris, France
来源
MEDECINE ET MALADIES INFECTIEUSES | 2005年 / 35卷 / 02期
关键词
hepatitis A; HIV infection; HAV vaccination;
D O I
10.1016/j.medmal.2004.09.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background - There are common risk factors between hepatitis A virus (HAV) and human immuno deficiency virus (HIV) infections. Then we tried to evaluate if HIV-infected patients could be at risk for HAV. More over, HAV could worsen prognosis of HIV infection and HAV vaccination was then to be considered. Objectives. - To assess the prevalence and risk factors of HAV infection in an HIV-infected population. Patients and methods. - 154 HIV-positive patients (mean age: 42 years, male patients: 70.8%, female patients: 29.2%) were screened for HAV antibodies and answered a questionnaire on risk factors for HAV and means of HIV contamination. Results. - The global prevalence was 72.7% [IC95%: 65.7-79.7]. When patients born in highly endemic areas were excluded seroprevalence reached 60% [IC95%: 51.2-70]. The HAV seroprevalence was almost 100% in migrants from highly endemic countries and for those born before 1946. The multivariate analysis showed that risk factors were the geographic origin [ORa = 20.88; IC95%: 2.40-18 1], age [ORa = 2.33; IC95%: 1.24-4.39], and hemophilia [ORa = 13.78; IC95%: 1.34-141]. Conclusion. - Our results suggest that a screening test for HAV antibodies should be performed before vaccination, especially in HIV-infected patients born after 1946 or in non-endemic countries. (c) 2005 Publie par Elsevier SAS.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 43 条
[11]   HEPATITIS-A IN FRENCH HEMOPHILIACS [J].
GOUDEMAND, J ;
PARQUET, A ;
DOIRON, R ;
STIELTJES, N ;
GUEROIS, C ;
FONLUPT, J ;
ALCALAY, M ;
NEGRIER, C ;
CAZENAVE, JP ;
BRIQUEL, ME ;
FRESSINAUD, E .
VOX SANGUINIS, 1994, 67 :9-13
[12]  
Grinde B, 1997, J MED VIROL, V53, P69, DOI 10.1002/(SICI)1096-9071(199709)53:1&lt
[13]  
69::AID-JMV12&gt
[14]  
3.0.CO
[15]  
2-S
[16]   AN EPIDEMIC OF HEPATITIS-A ATTRIBUTABLE TO THE INGESTION OF RAW CLAMS IN SHANGHAI, CHINA [J].
HALLIDAY, ML ;
KANG, LY ;
ZHOU, TK ;
HU, MD ;
PAN, QC ;
FU, TY ;
HUANG, YS ;
HU, SL .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (05) :852-859
[17]   OUTBREAKS OF HEPATITIS-A AMONG ILLICIT DRUG-USERS, OKLAHOMA, 1984-87 [J].
HARKESS, J ;
GILDON, B ;
ISTRE, GR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1989, 79 (04) :463-466
[18]   A COMMUNITY-WIDE OUTBREAK OF HEPATITIS-A - RISK-FACTORS FOR INFECTION AMONG HOMOSEXUAL AND BISEXUAL MEN [J].
HENNING, KJ ;
BELL, E ;
BRAUN, J ;
BARKER, ND .
AMERICAN JOURNAL OF MEDICINE, 1995, 99 (02) :132-136
[19]   Multiple modes of hepatitis A virus transmission among methamphetamine users [J].
Hutin, YJF ;
Sabin, KM ;
Hutwagner, LC ;
Schaben, L ;
Shipp, GM ;
Lord, DM ;
Conner, JS ;
Quinlisk, MP ;
Shapiro, CN ;
Bell, BP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (02) :186-192
[20]   AN OUTBREAK OF HEPATITIS-A AMONG IRISH HEMOPHILIACS [J].
JOHNSON, Z ;
THORNTON, L ;
TOBIN, A ;
LAWLOR, E ;
POWER, J ;
HILLARY, I ;
TEMPERLEY, I .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) :821-828